In The Psychiatry Letter, we will present lessons from a complete course in psychopharmacology. The first lesson is about the big picture: There are two ways of approaching psychopharmacology:
PL recommends the second. What's the difference? Don't say: I'll use drug x because it affects serotonin and norepinpehrine, which is theoretically better than just affecting one of those neurotransmitters. Ask the question: What is the clinical research evidence that drug x is effective for patients with a specific clinical condition?
If you take this approach, you will be more scientifically sound in your decision-making, and less biologically speculative. To do so, you'll have to ignore some of the major texts of psychopharmacology, and look to the clinical research studies themselves. PL will help.